Intensified CHOP with Rituximab for Intermediate or High-Risk Non-Hodgkin’s Lymphoma: Interim Analysis of a Randomized Phase III Trial in Elderly Patients by the Dutch HOVON and Nordic Lymphoma Groups.
暂无分享，去创建一个
H. Holte | P. Sonneveld | M. Eriksson | W. van Putten | P. Huijgens | W. Putten | P. Wijermans | D. Biesma | M. Kramer | M. Steijaert | M. V. Marwijk-Kooy | M. van Marwijk-Kooy | Monique M. C Steijaert